#46 - Robot replacements, Unprofitable buybacks, Objective Corp, Genetic Signatures, & Catapult Artwork

Baby Giants Investing

Join us as we chat about the wild, weird, and whacky of small cap investing, all while searching for those precious few fast-growing businesses that have a shot of becoming industry giants. (Intro music by Skilsel)

All Episodes

Baby Giants Investing

#46 - Robot replacements, Unprofitable buybacks, Objective Corp, Genetic Signatures, & Catapult

September 23, 2022 • BabyGiants • Episode 46

Andrew, Matt and Claude, chat through some positive developments in AI and immunology, Charter Hall CEO David Harrison's controversial claim, Russia's conscription, and we answer your questions (oOh!Media, Objective Corporation, Pro Medicus, Genetic Signatures), and Catapult Group International.

-----

1:04 - Good News: AI

3:51 - Good News: Immunology and lupus

4:43 - Charter Hall (ASX: CHC) CEO's controversial claim

12:30 - Biden says U.S. would defend Taiwan

14:38 - Russia's conscription

16:02 - oOh!Media's (ASX: OML) buyback

24:01 - Objective Corporation (ASX: OCL) (1)

30:33 - Pro Medicus (ASX: PME)

32:02 - Objective Corporation (ASX: OCL) (2)

39:27 - Genetic Signatures (ASX: GSS)

41:42 - Catapult Group International (ASX: CAT)